Results 161 to 170 of about 39,882 (218)

Reviewed article: Borralho PM, Pavan E, Azevedo FKSF, Fontes CJF, Figueiredo AB, Brito WI, Yamanaka FR, Oliveira RG. Prevalence of human T-cell lymphotropic virus in blood donor screening at the Blood Center: a descriptive study, Mato Grosso, 2018-2021. Epidemiol Serv Saude. 2025:34;e20240799. [PDF]

Epidemiol Serv Saude
Reis IA.
europepmc   +1 more source

Assessment of Awareness and Knowledge Regarding Human T-Lymphotropic Virus Type 1 (HTLV-1) Among Healthcare Workers at Imam Khomeini Hospital Complex, Tehran, in 2023-2024, A Cross-Sectional Descriptive-Analytical Study. [PDF]

Health Sci Rep
Letafati A, Goudarzi Y, Sheikhi M, Afzali M, Norouzi M, Rouzbahani KA, Ghasemi M, Sadeghi A, Mozhgani SH.   +8 more
europepmc   +1 more source

Chronic course of human T-cell lymphotropic virus type-1-associated bronchioloalveolar disorder diagnosed using transbronchial lung cryobiopsy. [PDF]

Respir Med Case Rep
Hiromi A, Yamakawa H, Ohta H, Kusano K, Adachi A, Yamaguchi Y, Matsushima H.   +6 more
europepmc   +1 more source

Dolutegravir use is related to lower HTLV-1 proviral load in people co-infected by HIV-1. [PDF]

Commun Med (Lond)
Fernandez T, Arriaga MB, Mayoral R, Netto EM, Brites C.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Human T lymphotropic virus‐1 infection

Australasian Journal of Dermatology, 1996
SUMMARYHuman T lymphotropic virus‐1 (HTLV‐1) is a retrovirus which infects T lymphocytes (CD4+) to cause adult T cell leukaemia/lymphoma (ATL), tropical spastic paraparesis and several other HTLV‐1 associated disorders. ATL has been reported worldwide but areas of high incidence include Japan (particularly the south‐west), Central and South America ...
T, Kanzaki, M, Setoyama, Y, Katahira
openaire   +2 more sources

Human T-lymphotropic virus type 1 infection

Best Practice & Research Clinical Haematology, 2000
Human T-cell lymphotropic virus type-1 (HTLV-1) is aetiologically associated with adult T-cell leukaemia/lymphoma (ATL). HTLV-1 infection can also lead to various non-malignant diseases, for example, HTLV-1 associated myelopathy/tropical spastic paraparesis and HTLV-1 uveitis. HTLV-1 is endemic in southern Japan and the Caribbean.
K, Tsukasaki, P, Koeffler, M, Tomonaga
openaire   +2 more sources

Human T-lymphotropic virus 1 neurologic disease

Current Treatment Options in Neurology, 2008
Human T-lymphotrophic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a disabling myelopathy, but clinical trials of specific drugs to treat it are lacking. There are many reasons for the absence of specific therapeutic studies, including difficulty in enrolling patients, inadequate measurement tools to evaluate ...
Abelardo, Araújo, Marco Antonio, Lima, Marcus Tulius T, Silva   +2 more
openaire   +2 more sources

Infection of defective human T-lymphotropic virus type 1

Human Cell, 2017
In a previous study, we reported that an identical defective provirus had integrated into multiple sites of the genome of a representative human T-lymphotropic virus type 1 (HTLV-1) cell line, MT-2. A possible explanation for this may be the repeated infection of this defective provirus to a cell.
Yuuki, Hashikura, Kazumi, Umeki, Kunihiko, Umekita, Hajime, Nomura, Akiteru, Yamada, Ikuo, Yamamoto, Hiroo, Hasegawa, Katsunori, Yanagihara, Akihiko, Okayama   +8 more
openaire   +2 more sources